Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BrainCells

BrainCells, INC (BCI) is a leading-edge neurogenesis-based drug discovery and development company targeting novel therapies for depression, mood disorders and other CNS diseases. Neurogenesis is emerging as a fundamental mechanism underlying CNS physiology and provides an opportunity for a paradigm-shifting approach to the treatment of CNS disease. BCI believes that, by targeting neurogenesis mechanisms with small molecule therapeutics, we will be able to develop and take to market first-in-class therapies for depression, mood disorders and other major CNS diseases.

Furthermore, BCI believes that the neurogenesis platform will provide a predictive pre-clinical model which will enhance the productivity of CNS drug research and reduce late-stage clinical attrition in the product pipeline.


Contact Details:
10835 Road To The Cure, Suite 150
San Diego
California
92121
United States of America
Tel:1 858 812 7700
Fax:1 858 812 7630
Email:ehodgkin@braincellsinc.com
WWW:

www.braincellsinc.com/




Loading...

Recent Publications by BrainCells:

The status of nutraceuticals for the treatment of depression.
Currently, there are no specific markers available for the early detection...
27th October, 2009
Dr. Targum is an executive-in-residence at Oxford BioScience Partners and Psychiatry (Edgmont). 2009 Sep;6(9):46-8.
Cognition and schizophrenia: is there a role for cognitive assessments in diagnosis and treatment?
Currently, there are no specific markers available for the early detection...
3rd September, 2009
Dr. Targum is an executive-in-residence at Oxford BioScience Partners and Psychiatry (Edgmont). 2008 Dec;5(12):55-9.
Clinical applications of neuroimaging for treating depressive disorders.
Currently, there are no specific markers available for the early detection...
3rd September, 2009
Dr. Targum is an executive-in-residence at Oxford BioScience Partners and Psychiatry (Edgmont). 2009 Jun;6(6):49-51.
Seasonal affective disorder.
Currently, there are no specific markers available for the early detection...
1st May, 2008
Dr. Targum is an executive-in-residence at Oxford BioScience Partners, on Psychiatry (Edgmont). 2008 May;5(5):31-3.
Biomarkers for the identification and treatment of dementia.
Currently, there are no specific markers available for the early detection...
1st February, 2008
Dr. Targum is an executive-in-residence at Oxford BioScience Partners and Psychiatry (Edgmont). 2008 Feb;5(2):51-6.

View more BrainCells research publications.

Press Releases on BrainCells:

BioPortfolio Logo
BrainCells Inc. Broadens Scientific Advisory Board Adding Drs. Edward Scolnick and David Holtzman 20th October, 2009 BrainCells Inc.
SAN DIEGO, Oct. 20 /PRNewswire/ -- BrainCells Inc., a company leading the scientific research of neurogenesis using its proprietary neural stem cell platform technology to identify novel pathways for
BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer 30th March, 2009 BrainCells Inc.
SAN DIEGO, March 30 /PRNewswire/ -- BrainCells Inc. (BCI), a company leading the scientific research of neurogenesis using its proprietary platform technology to identify novel pathways for the

BioNews Results for BrainCells:

Depression Treatments Reviewed by NeuroInvestment
PR-USA.net:  Nov 8 2009 12:38AM Matching: braincells
Depression Treatments Reviewed by NeuroInvestment
Genetic Engineering News:  Nov 4 2009 6:35PM Matching: braincells
Depression Treatments Reviewed by NeuroInvestment
Street Insider:  Nov 4 2009 6:12PM Matching: braincells
Depression Treatments Reviewed by NeuroInvestment
Marketwire via Yahoo!:  Nov 4 2009 5:42PM Matching: braincells
Depression Treatments Reviewed by NeuroInvestment
Stockwatch:  Nov 4 2009 5:39PM Matching: braincells
Promote your company here: BioNewsCast - Press Release Distribution

View more BrainCells news.

BrainCells Clinical Trials:

Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 275 times since April 2007, the link to the organisation's website has been followed 47 times

Search for more companies in San Diego

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for BrainCells

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.